article · Journal of International Medical Research
BackgroundThe World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is a widely used instrument for assessing functioning and disability across various health conditions. However, there is limited research on its validation in the context of potentially life-threatening maternal conditions.ObjectiveTo validate the Tigrigna version of WHODAS 2.0 in women with potentially life-threatening maternal conditions during the immediate postpartum period.MethodsThis cross-sectional study was conducted in hospitals in Tigray, Ethiopia. The Tigrigna version of the WHODAS 2.0 was administered to 121 women with potentially life-threatening maternal conditions. Internal consistency was evaluated using Cronbach's alpha, convergent validity was preliminarily assessed using Spearman's correlation, and construct validity was assessed using confirmatory factor analysis.ResultThe 36-item Tigrigna version showed adequate internal consistency for all domain scores, with Cronbach's alpha values ranging from 0.89 to 0.96 and a summary score Cronbach's alpha of 0.98. Except for Domains 1 and 2, convergent validity between the 36-item and 12-item versions was demonstrated by strong correlations between similar constructs, with correlation coefficients ranging from 0.86 to 0.96. Confirmatory factor analysis indicated a poor or suboptimal fit for the six-domain model, with a root mean square error of approximation of 0.13, a comparative fit index of 0.84, and a Tucker-Lewis index of 0.82.ConclusionThis preliminary validation suggests that the Tigrigna version of WHODAS 2.0 demonstrates acceptable reliability and validity for assessing disability in women with a history of potentially life-threatening maternal conditions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1177/03000605251411670
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.